canagliflozin
Commercial- Indications
- Type 2 diabetes
Company intelligence / Profile preview
The Institutes for Pharmaceutical Discovery was a private research organization specializing in early-stage drug discovery. It combined the expertise of senior pharmaceutical executives with industry researchers to address unmet medical needs through innovative programs. The company engaged in partnerships such as computational chemistry services but ultimately ceased operations due to lack of funding. No clinical results are publicly available.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Institutes for Pharmaceutical Discovery.